News & Events
-
February 1, 2017
Validity of Low-Contrast Letter Acuity as a Visual Performance Outcome Measure for Multiple Sclerosis
Balcer LJ, Raynowska J, Nolan R, Galetta SL, Kapoor R, Benedict R, Phillips G, LaRocca N, Hudson L, Rudick R, Multiple Sclerosis Outcome Assessments Consortium. Validity of Low-Contrast Letter Acuity as a Visual Performance Outcome Measure for Multiple Sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 2017 Feb 1;23(5):734–7.
-
February 1, 2017
The Nine-Hole Peg Test as a Manual Dexterity Performance Measure for Multiple Sclerosis
Feys P, Lamers I, Francis G, Benedict R, Phillips G, LaRocca N, Hudson LD, Rudick R, Multiple Sclerosis Outcome Assessments Consortium. The Nine-Hole Peg Test as a Manual Dexterity Performance Measure for Multiple Sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 2017 Apr;23(5):711–20.
-
February 1, 2017
Validity of the Timed 25-Foot Walk as an Ambulatory Performance Outcome Measure for Multiple Sclerosis
Motl RW, Cohen JA, Benedict R, Phillips G, LaRocca N, Hudson LD, Rudick R, Multiple Sclerosis Outcome Assessments Consortium. Validity of the Timed 25-Foot Walk as an Ambulatory Performance Outcome Measure for Multiple Sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 2017 Apr;23(5):704–10.
-
February 1, 2017
A Drug Development Tool for Trial Enrichment in Patients With Autosomal Dominant Polycystic Kidney Disease
Perrone RD, Mouksassi MS, Romero K, Czerwiec FS, Chapman AB, Gitomer BY, Torres VE, Miskulin DC, Broadbent S, Marier JF. A Drug Development Tool for Trial Enrichment in Patients With Autosomal Dominant Polycystic Kidney Disease. Kidney International Reports. 2017 Feb.
-
February 1, 2017
Validity of the Symbol Digit Modalities Test as a Cognition Performance Outcome Measure for Multiple Sclerosis
Benedict RH, DeLuca J, Phillips G, LaRocca N, Hudson LD, Rudick R, Multiple Sclerosis Outcome Assessments Consortium. Validity of the Symbol Digit Modalities Test as a Cognition Performance Outcome Measure for Multiple Sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 2017 Apr;23(5):721–33.